A migraine drugmaker heads to the public markets through reverse merger
HealthcareNew YorkMerger
InMed Pharmaceuticals→Mentari Therapeutics
May 19, 2026
Tracking 1 M&A deal by InMed Pharmaceuticals.
InMed Pharmaceuticals→Mentari Therapeutics
May 19, 2026